Bridging heterogeneous mutation data to enhance disease gene discovery
暂无分享,去创建一个
K. Bretonnel Cohen | Jin-Dong Kim | Yuxing Wang | Kaiyin Zhou | Jingbo Xia | Xiaohang Ma | Zhixue Shen | Xiangyu Meng
[1] Anastasia G. Efthymiou,et al. Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk , 2017, Molecular Neurodegeneration.
[2] Yuxing Wang,et al. An Overview of the Active Gene Annotation Corpus and the BioNLP OST 2019 AGAC Track Tasks , 2019, EMNLP.
[3] A. Butte,et al. Leveraging models of cell regulation and GWAS data in integrative network-based association studies , 2012, Nature Genetics.
[4] Helen E. Parkinson,et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..
[5] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[6] Peter Tontonoz,et al. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors , 2007, Proceedings of the National Academy of Sciences.
[7] Nick C Fox,et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.
[8] Gautier Koscielny,et al. Open Targets: a platform for therapeutic target identification and validation , 2016, Nucleic Acids Res..
[9] Ferdinando Di Cunto,et al. Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs , 2011, Cell.
[10] K. Lunetta,et al. Transethnic genome-wide scan identifies novel Alzheimer's disease loci , 2017, Alzheimer's & Dementia.
[11] M. Shoji,et al. MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis , 2019, Neuroscience Letters.
[12] Nick C Fox,et al. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.
[13] Xia Li,et al. Gain-of-Function Mutations: An Emerging Advantage for Cancer Biology. , 2019, Trends in biochemical sciences.
[14] A. Ciccodicola,et al. Non-coding RNA and pseudogenes in neurodegenerative diseases: “The (un)Usual Suspects” , 2012, Front. Gene..
[15] Qingdong Guo,et al. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease , 2017, BioMed research international.
[16] A. Quinlan. BEDTools: The Swiss‐Army Tool for Genome Feature Analysis , 2014, Current protocols in bioinformatics.
[17] Michael I. Jordan,et al. Latent Dirichlet Allocation , 2001, J. Mach. Learn. Res..
[18] Wei Zheng,et al. dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks , 2011, Bioinform..
[19] J. Gallacher,et al. Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing , 2018, bioRxiv.
[20] Ulf Leser,et al. SETH detects and normalizes genetic variants in text , 2016, Bioinform..
[21] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.
[22] Weiming Xia,et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.
[23] T. Raj,et al. Untangling Genetic Risk for Alzheimer’s Disease , 2018, Biological Psychiatry.
[24] H. Hakonarson,et al. Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.
[25] F. LaFerla. Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.
[26] Hong-yu Zhang,et al. Rational drug repositioning by medical genetics , 2013, Nature Biotechnology.
[27] Zhongming Zhao,et al. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes , 2016, Briefings Bioinform..
[28] O. Andreassen,et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer’s disease , 2018, Acta Neuropathologica.
[29] Jin-Dong Kim,et al. An Active Gene Annotation Corpus and Its Application on Anti-epilepsy Drug Discovery , 2019, 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
[30] Jing Cheng,et al. The emerging role of microRNA-4487/6845-3p in Alzheimer’s disease pathologies is induced by Aβ25–35 triggered in SH-SY5Y cell , 2018, BMC Systems Biology.
[31] Na He,et al. Optimization of in silico tools for predicting genetic variants: individualizing for genes with molecular sub-regional stratification , 2020, Briefings Bioinform..
[32] S. Leurgans,et al. Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. , 2011, Journal of Alzheimer's disease : JAD.
[33] M. Nöthen,et al. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene , 2014, Translational Psychiatry.
[34] Margaret A. Pericak-Vance,et al. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease , 2006, Neurobiology of Disease.
[35] G. Tesco,et al. The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation* , 2016, The Journal of Biological Chemistry.
[36] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[37] Shubhabrata Mukherjee,et al. Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments , 2017, Alzheimer's & Dementia.
[38] Young-Kook Kim,et al. Identification of the Role of miR-142-5p in Alzheimer’s Disease by Comparative Bioinformatics and Cellular Analysis , 2017, Front. Mol. Neurosci..
[39] Nick C Fox,et al. Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease , 2014, PLoS ONE.
[40] H. Stefánsson,et al. Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease , 2015, Nature Genetics.
[41] Jin Liu,et al. IGESS: a statistical approach to integrating individual‐level genotype data and summary statistics in genome‐wide association studies , 2017, Bioinform..
[42] A. Singleton,et al. TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.
[43] M. Wooten,et al. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease , 2009, Neurobiology of Disease.
[44] M. Lindberg,et al. GSK3β is a negative regulator of the transcriptional coactivator MAML1 , 2009, Nucleic acids research.
[45] T. Wyss-Coray,et al. Complement Receptor 2 Is Expressed in Neural Progenitor Cells and Regulates Adult Hippocampal Neurogenesis , 2011, The Journal of Neuroscience.
[46] C. Ramírez,et al. miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression , 2012, Experimental Neurology.
[47] G. Johnson,et al. The role of tau phosphorylation and cleavage in neuronal cell death. , 2007, Frontiers in bioscience : a journal and virtual library.